Return to search results
Pemetrexed
Pemetrexed is a prescription chemotherapy drug used to treat certain cancers, like non-small cell lung cancer and malignant pleural mesothelioma. It works by blocking folate metabolism in cancer cells. Given intravenously as a solution in vials of 100mg, 500mg, or 1g, it's manufactured by Teva Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Pemetrexed is a prescription chemotherapy drug used to treat certain cancers, like non-small cell lung cancer and malignant pleural mesothelioma. It works by blocking folate metabolism in cancer cells. Given intravenously as a solution in vials of 100mg, 500mg, or 1g, it's manufactured by Teva Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Pemetrexed",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Pemetrexed — ANDA 216582 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216582"
}
]
|
| identifier | ANDA216582 |
| issued | 2016-09-16 |
| keyword |
[
"drug-safety",
"fda",
"health-care",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Pemetrexed |
